Occupational Activity – Page 10

Samsung Biologics Embarks on New Phase of Growth with Bio Campus II and ADC Services

3 months ago talkbio0Tagged Antibody-Drug Conjugates, Bio Campus II, Biological Factors, Capacity, CDMO, Contract agreement, development aspects, digital transformation, expansion, Manufacturing Organization, Plants, Samsung, Services

Samsung Biologics, Bio Campus II, Plant 5, antibody-drug conjugate (ADC) services, capacity expansion, digital transformation, contract development and manufacturing organization (CDMO)

GSK Advances Liver Disease Research and Biotech CEO Sisterhood Grows Influence

3 months ago talkbio0Tagged biotech, CEO, Drug Industry, JPM25, Liver diseases, sisterhood, SmithKline Beecham, Women

GSK, liver disease, Biotech CEO Sisterhood, JPM25, pharmaceutical industry, women in biotech

Key Takeaways from #JPM25: Strategic Partnerships and Acquisitions Dominate the JP Morgan Healthcare Conference

3 months ago talkbio0Tagged Acquisitions, Biopharma, Eli, Eli Lilly, Industry, J.P. Morgan Healthcare, JPM25, partnerships, Pharma, Scorpions, SmithKline Beecham, Zealand

JP Morgan Healthcare Conference, #JPM25, biopharma industry, acquisitions, partnerships, Eli Lilly, Zealand Pharma, GSK, Scorpion Therapeutics

IGM Biosciences Halts Autoimmune Projects Amid Layoffs Following Disappointing Trial Data

4 months ago talkbio0Tagged Autoimmune Diseases, Biosciences, bispecific antibody T cell, engagers, IGM-2644, Immunoglobulin M, imvotamab, Industry

IGM Biosciences, layoffs, autoimmune diseases, bispecific antibody T cell engagers, imvotamab, IGM-2644, biotech industry

Revance Therapeutics Faces Competing Buyout Offers: Teoxane SA Outbids Crown Laboratories

4 months ago talkbio0Tagged Biotechnology, Crown Laboratories, Industry, Revance, sulfanilamide, Teoxane

Revance Therapeutics, Teoxane SA, Crown Laboratories, buyout offers, merger agreement, biotechnology, skincare industry

WuXi Biologics Divests Irish Vaccine Facility to Merck for $500 Million Amid Strategic Shift

4 months ago talkbio0Tagged asset, Biological Factors, BIOSECURE, Dundalk, Facility (object), Ireland, Merck, regulatory, Sales - occupational activity, strategic shift, Vaccines, WuXi

WuXi Biologics, Merck, vaccine manufacturing facility, Dundalk, Ireland, asset sale, strategic shift, regulatory changes, Biosecure Act

Carecode Revolutionizes Brazilian Healthcare with AI-Powered Customer Service, Secures $4.3M Funding

4 months ago talkbio0Tagged Aortic Valve Insufficiency, Artificial Intelligence, Automation, brazilian, Carecode, Customer, Health care facility, Services

Carecode, AI, Healthcare, Customer Service, Automation, Funding, Brazilian Healthcare

FDA Imposes Import Restrictions on 11 Viatris Products from Indian Facility Due to Regulatory Violations

4 months ago talkbio0Tagged Facility (object), Import, pharmaceutical manufacturing, Regulatory Violations, restrictions, United States Food and Drug Administration, Viatris

Viatris, FDA, Import Restrictions, India Facility, Regulatory Violations, Pharmaceutical Manufacturing

Javara Undergoes Restructuring, Lays Off Staff Amidst Industry-Wide Challenges

4 months ago talkbio0Tagged Biopharma, Clinical Research, Industry, Javara, restructuring

Javara, layoffs, restructuring, clinical research, biopharma industry challenges

Ring Therapeutics Undergoes Significant Restructuring, Laying Off Nearly Half of Its Workforce

4 months ago talkbio0Tagged Industry, restructuring, Ring (shape)

Ring Therapeutics, layoffs, workforce reduction, biotech industry, restructuring